Log In
BCIQ
Print this Print this
 

imetelstat (GRN163L, JNJ-63935937)

  Manage Alerts
Collapse Summary General Information
Company Geron Corp.
DescriptionOligonucleotide that competitively inhibits telomerase activity
Molecular Target Telomerase
Mechanism of ActionTelomerase inhibitor
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$935.0M

$35.0M

$900.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/13/2014

$935.0M

$35.0M

$900.0M

Get a free BioCentury trial today